| scholarly article | Q13442814 |
| P2093 | author name string | Erin B Lavik | |
| Andrew J Shoffstall | |||
| Jeffrey S Ustin | |||
| Lydia M Everhart | |||
| Matthew E Varley | |||
| Adam M Shick | |||
| Eric S Soehnlen | |||
| P2860 | cites work | Causes of death in U.S. Special Operations Forces in the global war on terrorism: 2001-2004 | Q24681461 |
| The epidemiology and modern management of traumatic hemorrhage: US and international perspectives | Q28192622 | ||
| Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank | Q30952903 | ||
| Comparative specificity of platelet alpha(IIb)beta(3) integrin antagonists. | Q31962311 | ||
| Novel platelet products, substitutes and alternatives | Q33338494 | ||
| Interactions of platelets with Synthocytes, a novel platelet substitute | Q33343845 | ||
| Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo | Q33369240 | ||
| Visualization of liposomes carrying fibrinogen gamma-chain dodecapeptide accumulated to sites of vascular injury using computed tomography | Q33385930 | ||
| Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage. | Q33402878 | ||
| Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits | Q33504864 | ||
| Engineering clustered ligand binding into nonviral vectors: alphavbeta3 targeting as an example | Q33713483 | ||
| Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen | Q33909935 | ||
| Platelet substitutes | Q34000375 | ||
| Gender differences in the blood volume of conscious Sprague-Dawley rats. | Q34468651 | ||
| A profile of combat injury | Q35136408 | ||
| Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions | Q35597837 | ||
| Treating traumatic bleeding in a combat setting. | Q36009730 | ||
| Treating traumatic bleeding in a combat setting: possible role of recombinant activated factor VII. | Q36009737 | ||
| Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. | Q36497423 | ||
| Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations | Q36501096 | ||
| Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide. | Q37140413 | ||
| Transfusion practice in military trauma | Q37206284 | ||
| Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide. | Q37383038 | ||
| Transfusion therapy in hemorrhagic shock | Q37591799 | ||
| Inorganic Nanoparticles in Cancer Therapy | Q37812005 | ||
| PLGA-based nanoparticles: an overview of biomedical applications. | Q37986980 | ||
| Noncompressible torso hemorrhage: a review with contemporary definitions and management strategies | Q38031053 | ||
| The upcoming field of theranostic nanomedicine: an overview | Q38048806 | ||
| Lessons from the tip of the spear: medical advancements from Iraq and Afghanistan | Q39573767 | ||
| Controlling Ligand Surface Density Optimizes Nanoparticle Binding to ICAM-1 | Q39648047 | ||
| Fibrin sealant foam sprayed directly on liver injuries decreases blood loss in resuscitated rats | Q40750768 | ||
| Intravenous hemostatic nanoparticles increase survival following blunt trauma injury | Q41215308 | ||
| Intravenous hemostat: nanotechnology to halt bleeding. | Q41470605 | ||
| Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility | Q41826178 | ||
| Influence of Targeting Ligand Flexibility on Receptor Binding of Particulate Drug Delivery Systems | Q42833947 | ||
| A simple synthetic route to the formation of a block copolymer of poly(lactic-co-glycolic acid) and polylysine for the fabrication of functionalized, degradable structures for biomedical applications | Q43586658 | ||
| Acute toxicity of intravenously administered microfabricated silicon dioxide drug delivery particles in mice: preliminary findings | Q43765615 | ||
| Liver injury as a model of uncontrolled hemorrhagic shock: resuscitation with different hypertonic regimens | Q46309466 | ||
| Preparation of poly(ethylene glycol) protected nanoparticles with variable bioconjugate ligand density | Q46401536 | ||
| Resuscitation of uncontrolled liver hemorrhage: effects on bleeding, oxygen delivery, and oxygen consumption | Q46833271 | ||
| Size and shape effects in the biodistribution of intravascularly injected particles. | Q47588670 | ||
| Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor | Q50132660 | ||
| Mimicking adhesive functionalities of blood platelets using ligand-decorated liposomes. | Q51759013 | ||
| Injury Severity and Causes of Death From Operation Iraqi Freedom and Operation Enduring Freedom: 2003???2004 Versus 2006 | Q56807533 | ||
| Interspecies differences in coagulation profile | Q60190171 | ||
| Frozen platelets and platelet substitutes in transfusion medicine | Q73656652 | ||
| Trauma and pulmonary thromboembolism: an experimental study on their correlation | Q80670603 | ||
| Peptide-decorated liposomes promote arrest and aggregation of activated platelets under flow on vascular injury relevant protein surfaces in vitro | Q83790128 | ||
| Efficacy of FDA-approved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage | Q83937026 | ||
| Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery | Q84927729 | ||
| In vitro and in vivo hemostatic capabilities of a functionally integrated platelet-mimetic liposomal nanoconstruct | Q85982195 | ||
| P433 | issue | 8 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 2790-2797 | |
| P577 | publication date | 2013-07-24 | |
| P1433 | published in | Biomacromolecules | Q1768006 |
| P1476 | title | Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma | |
| P478 | volume | 14 |
| Q37531135 | Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice |
| Q60998516 | Engineering Intravenously Administered Nanoparticles to Reduce Infusion Reaction and Stop Bleeding in a Large Animal Model of Trauma |
| Q37278074 | Hemostatic Nanoparticles Improve Survival Following Blunt Trauma Even after 1 Week Incubation at 50 °C. |
| Q57376754 | Hemostatic polymers: the concept, state of the art and perspectives |
| Q38168784 | Hemostatic strategies for traumatic and surgical bleeding |
| Q30584438 | Intravenously administered nanoparticles increase survival following blast trauma |
| Q41915826 | Materials design at the interface of nanoparticles and innate immunity. |
| Q50915888 | Peptide valency plays an important role in the activity of a synthetic fibrin-crosslinking polymer. |
| Q38813909 | Surgical adjuncts to noncompressible torso hemorrhage as tools for patient blood management |
| Q35858739 | Synthetic Strategies for Engineering Intravenous Hemostats |
| Q48267294 | Thrombin@Fe3O4 nanoparticles for use as a hemostatic agent in internal bleeding. |
| Q27026630 | Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm |
Search more.